Vitamin B12 tests: what do B12, MMA and homocysteine results mean?

What is a B12 test trying to establish?

Short answer: a B12 result is one clue, not a diagnosis. B12 supports nerves and blood cells. A clinician considers whether the body has enough usable B12 and whether a deficiency could explain symptoms. Some people with deficiency have neurological symptoms without anaemia, so the clinical picture matters as well as the number. For symptoms and possible causes, begin with the vitamin B12 overview.42

What are total and active B12?

A total B12 test measures B12 in the blood; an active B12 test estimates the portion carried in a form available to cells. The test selected depends on the clinical situation and local guidance. For suspected deficiency during pregnancy, the UK NICE guideline recommends active B12 as the initial test. A low or borderline result is a clue to discuss, not a complete explanation of symptoms; reference ranges and units vary by laboratory.13

In its guidance for people aged 16 and over, NICE describes total B12 of 180–350 ng/L (133–258 pmol/L), or active B12 of 25–70 pmol/L, as an indeterminate result: deficiency is possible. Where validated total-B12 thresholds vary substantially, NICE advises clinicians to use the testing laboratory’s thresholds. With symptoms or signs and an indeterminate result, a clinician may consider a serum MMA test. These numbers are guidance for assessment, not a diagnosis or a reason to delay care.1

NICE also notes that serum B12 reference ranges may be higher for people of Black ethnicity than for people of White or Asian ethnicity, based on UK population evidence. This is a consideration for clinical interpretation, not a way to determine an individual’s result or diagnosis from ethnicity. Discuss the result alongside symptoms, the laboratory method and any further tests.1

Why might a clinician measure MMA or homocysteine?

Methylmalonic acid and homocysteine are substances involved in normal metabolism. They can rise when B12-dependent processes are not working adequately. A clinician may use them when an initial result is uncertain or in specific circumstances such as suspected nitrous oxide-related deficiency. They are not perfect B12-only tests: kidney function can affect both, and low folate can also raise homocysteine. Learn more about folate and its relationship with B12.13

Can supplements change a result?

Yes. NICE notes that B12 supplements, including tablets, injections or patches, can raise measured B12 without fully treating a deficiency. Tell the clinician exactly what you take or have taken, including the type and amount. The combined oral contraceptive pill can lower total B12 without necessarily causing deficiency, although a low result may still indicate deficiency. Do not stop prescribed treatment or delay necessary assessment to try to produce a particular test result.1

For people receiving intramuscular B12 replacement, NICE advises clinicians not to repeat the initial diagnostic test. This does not mean that follow-up or other blood tests are never needed: discuss symptoms and the plan with your clinician.2

Why is nitrous oxide a special case?

Nitrous oxide can inactivate B12, so a total or active blood level may appear normal despite a functional problem. NICE recommends MMA or homocysteine as the initial test in people aged 16 and over when deficiency caused by recreational nitrous oxide is suspected. Tell the clinician about exposure and symptoms; do not interpret a normal B12 result as proof that nerves are unaffected. Read the nitrous oxide guide.12

Should someone wait for results before getting help?

No. New or worsening neurological symptoms deserve prompt assessment. NICE advises clinicians not to delay B12 replacement while waiting for results in certain people with suspected megaloblastic anaemia and neurological symptoms. NICE recommends taking diagnostic blood samples before replacement starts; treatment and testing should be arranged by the clinician, without waiting for results when urgent treatment is indicated. The clinician decides what is needed; do not delay care to arrange a test or start a self-selected treatment plan.

NICE also advises clinicians to consider replacement after an indeterminate initial result in certain situations, including pregnancy or breastfeeding, or symptoms that may deteriorate rapidly. If an MMA test is also being arranged in these circumstances, NICE advises starting replacement while awaiting that result. This is a clinical decision, not a rule that everyone with a borderline result needs the same treatment.14

What should I ask about my result?

Ask what was measured, how the result relates to the laboratory’s range, whether supplements or other conditions affect it, and what the next step is if symptoms continue. A normal-looking number does not explain every symptom, and an abnormal marker does not identify a cause by itself. For a practical review of another nutrient that can affect nerves, see B6, B12 and nerve symptoms.32